Compare NTRB & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTRB | PIII |
|---|---|---|
| Founded | 2016 | 2015 |
| Country | United States | United States |
| Employees | 3 | 320 |
| Industry | Industrial Specialties | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.4M | 37.5M |
| IPO Year | N/A | N/A |
| Metric | NTRB | PIII |
|---|---|---|
| Price | $3.53 | $11.04 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 8.7K | ★ 3.6M |
| Earning Date | 05-29-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $30.17 | $7.67 |
| Revenue Next Year | $3,394.36 | $2.36 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.21 | $1.52 |
| 52 Week High | $11.68 | $16.89 |
| Indicator | NTRB | PIII |
|---|---|---|
| Relative Strength Index (RSI) | 48.07 | 57.04 |
| Support Level | $3.44 | $2.84 |
| Resistance Level | $3.69 | $16.89 |
| Average True Range (ATR) | 0.16 | 2.42 |
| MACD | 0.02 | -0.32 |
| Stochastic Oscillator | 79.21 | 41.01 |
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.